Biote (BTMD) vs FitLife Brands (FTLF)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
FitLife Brands (FTLF) has outperformed Biote (BTMD) over the past year, losing 65.9% versus a loss of 68.9%. Over five years, FTLF leads with a +3.3% price change compared with -91.6% for BTMD. FitLife Brands is the larger company by market cap ($58.2 million vs $26.3 million), about 2.2 times the size, while Biote is growing revenue faster (-2.5% vs -75.3%).
On valuation, Biote trades at a lower forward P/E (3.3x vs 5.3x for FitLife Brands). Biote converts more of its revenue into profit, with a net margin of 14.1% versus 12.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BTMD | FTLF |
|---|---|---|
| Share price | $0.8147 | $6.20 |
| Market cap | $26.28M | $58.22M |
| 1-day change | -3.56% | -7.46% |
| YTD return | -68.67% | -61.89% |
| 1-year return | -68.90% | -65.92% |
| 5-year return | -91.64% | +3.33% |
| P/E ratio (TTM) | — | 8.99 |
| Forward P/E | 3.33 | 5.25 |
| EPS (TTM) | $-0.07 | $0.69 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $192.22M | $15.94M |
| Revenue growth (YoY) | -2.52% | -75.28% |
| Net income (latest FY) | $27.05M | $2.02M |
| Gross margin | 71.46% | 43.14% |
| Operating margin | 18.50% | 18.56% |
| Net margin | 14.07% | 12.66% |
| 52-week high | $2.90 | $19.23 |
| 52-week low | $0.81 | $6.07 |
| Distance from 52-week high | -71.91% | -67.76% |
| Analyst consensus | none | none |
| Avg. price target upside | +220.36% | +182.26% |
| Average volume | 146.21K | 13.01K |
| Shares outstanding | 27.04M | 9.39M |
| Employees | 223 | 81 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- FitLife Brands is about 2.2 times larger than Biote by market value ($58.22M vs $26.28M).
- Biote grew revenue faster in its latest fiscal year (-2.52% vs -75.28%).
About Biote
BTMD stock →biote Corp. operates in practice-building business within the hormone optimization space.
Health Care · Medicinal Chemicals and Botanical Products · 223 employees
About FitLife Brands
FTLF stock →FitLife Brands, Inc. provides nutritional supplements and wellness products for health-conscious consumers in the United States and internationally.
Health Care · Medicinal Chemicals and Botanical Products · 81 employees
BTMD vs FTLF FAQ
Which is bigger, Biote or FitLife Brands?
FitLife Brands (FTLF) is larger, with a market capitalization of $58.22M compared with $26.28M for Biote (BTMD).
Which stock has performed better over the past year, BTMD or FTLF?
FTLF returned -65.92% over the past 12 months, compared with -68.90% for BTMD (price return, excluding dividends). Past performance does not predict future results.
Are Biote and FitLife Brands in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.